In hospitalized patients with IPF and type 2 diabetes, age, impaired lung function, and fibrosis burden independently ...
A new study has identified intermediate cells within the remodeled pulmonary parenchyma in idiopathic pulmonary fibrosis (IPF ...
In a recent study, lung ultrasound surface wave elastography showed no significant association with lung function impairment, ...
A KIT N822K mutation was found after progression in a boy with advanced systemic mastocytosis (SM) resistant to several lines ...
Lysosomotropic therapies such as hydroxychloroquine warrant caution in Fabry disease, as demonstrated in a case series.
Patients with AQP4-positive NMOSD who converted to seronegativity had a median annualized relapse rate of 0 in a Chinese ...
Admilparant met the primary endpoint of the pivotal phase 3 ALOFT-IPF trial at its lower dose in adults with IPF.
Patients with ITP treated with thrombopoietin receptor agonists as a second-line therapy had a longer time to next treatment ...
Forgetting to take medication represents the leading driver of suboptimal adherence to long-term prophylaxis in HAE, a study ...
HSCT was linked to higher blood count normalization and failure-free survival rates than symptomatic treatment in patients ...
In a Huntington disease (HD) mouse model, an HSP90 inhibitor reduced mHTT aggregation and improved cognitive function and ...
According to a recent study, treatment trajectories for Wilson disease differ markedly across specialized German centers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results